NovaBay Pharmaceuticals Inc (NBY) — Cash Flow-to-Debt Ratio
NovaBay Pharmaceuticals Inc (NBY) has a Cash Flow-to-Debt Ratio of -0.07x as of December 2025, meaning its operating cash flow of $-2.27 Million could theoretically repay 0% of its total liabilities ($31.86 Million) in one year. See NovaBay Pharmaceuticals Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
NovaBay Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2005–2025)
Historical debt coverage capacity for NovaBay Pharmaceuticals Inc across 21 annual periods. Also explore net asset growth rate of NovaBay Pharmaceuticals Inc to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for NovaBay Pharmaceuticals Inc (2005–2025)
Year-by-year debt coverage analysis for NovaBay Pharmaceuticals Inc. For market capitalisation and broader financial context, see market value of NovaBay Pharmaceuticals Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.26x | $-8.43 Million | $31.86 Million | ▲ +81.9% |
| 2024 | -1.46x | $-5.18 Million | $3.55 Million | ▼ -95.9% |
| 2023 | -0.74x | $-4.26 Million | $5.72 Million | ▲ +34.6% |
| 2022 | -1.14x | $-6.65 Million | $5.84 Million | ▼ -71.0% |
| 2021 | -0.67x | $-9.19 Million | $13.81 Million | ▲ +58.8% |
| 2020 | -1.62x | $-4.72 Million | $2.92 Million | ▼ -108.9% |
| 2019 | -0.77x | $-7.93 Million | $10.25 Million | ▲ +38.8% |
| 2018 | -1.26x | $-5.57 Million | $4.41 Million | ▼ -50.8% |
| 2017 | -0.84x | $-6.27 Million | $7.49 Million | ▲ +42.8% |
| 2016 | -1.47x | $-12.13 Million | $8.28 Million | ▲ +19.6% |
| 2015 | -1.82x | $-18.56 Million | $10.18 Million | ▲ +31.1% |
| 2014 | -2.65x | $-15.05 Million | $5.69 Million | ▼ -45.6% |
| 2013 | -1.82x | $-12.97 Million | $7.13 Million | ▼ -44.4% |
| 2012 | -1.26x | $-6.53 Million | $5.19 Million | ▼ -165.2% |
| 2011 | -0.47x | $-3.14 Million | $6.62 Million | ▼ -217.6% |
| 2010 | 0.40x | $2.03 Million | $5.03 Million | ▲ +202.3% |
| 2009 | -0.39x | $-1.65 Million | $4.18 Million | ▲ +73.7% |
| 2008 | -1.50x | $-9.94 Million | $6.62 Million | ▼ -129.8% |
| 2007 | -0.65x | $-6.27 Million | $9.60 Million | ▼ -238.4% |
| 2006 | 0.47x | $4.74 Million | $10.05 Million | ▲ +104.5% |
| 2005 | -10.42x | $-3.23 Million | $310.00K | — |